Imaging of immunotherapy

1. To describe the characteristics of response to immunotherapy.
2. To understand pseudoprogression and how to differentiate a pseudoprogression from a true progression.
3. To describe the major immune-related adverse events and their potential misinterpretation as new lesions.

1. To learn about morphological criteria-based response assessment in immunotherapy (iRECIST and friends).
2. To appreciate the added value of metabolic and hybrid response assessment criteria (PERCIST, EORTC, and PERCRIT).
3. To become acquainted with novel molecular imaging techniques for monitoring the response to immunotherapy.

1. To recognise the spectrum of imaging findings of immune-related adverse events (irAEs) in major organs.
2. To understand the role of imaging in detection, diagnosis, and monitoring of irAEs.
3. To understand the importance of the multidisciplinary approach to irAEs.